Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)
Title:
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)
Author:
Decker, Thomas Lüdtke-Heckenkamp, Kerstin Melnichuk, Luidmila Hirmas, Nader Lübbe, Kristina Zahn, Mark-Oliver Schmidt, Marcus Denkert, Carsten Lorenz, Ralf Müller, Volkmar Zahm, Dirk-Michael Mundhenke, Christoph Bauer, Stefan Thill, Marc Seropian, Peter Filmann, Natalie Loibl, Sibylle